Syntegon’s Oral Solid Dosage product line continues to advance and offer unsurpassed technologies and innovation for our customers and their manufacturing needs. Our newest product offering comes in the form of a drum coater that we call, Sepion. The Sepion builds on decades of expertise from …more
With pharmaceutical companies increasing development of highly potent drugs, manufacturers of those drug products, both innovator companies and contract manufacturers alike, continue to seek better contained manufacturing equipment to ensure protection of both personnel and products.
While potent drug products come in a variety of dosage forms and potencies, …more
Syntegon Pharma Technology is pleased to announce the completion of a major capital investment program with our partners, Parsolex GMP Center. This investment consists of the installation of multiple pieces of equipment to enhance Parsolex’s existing analytical, development and cGMP manufacturing capabilities. The upgraded facility includes …more
Continuous Manufacturing has steadily gained momentum within the Oral Solid Dosage (OSD) industry over the last handful of years. Seeking significantly faster product development, reduced production costs, and higher yields, many pharmaceutical companies have made a concerted effort to implement continuous manufacturing lines within their production facilities. Continuous Manufacturing can allow inefficient batch processing to be a relic of the past, being replaced with smart sensing technology and unsurpassed product quality. …more
Be sure to visit Syntegon at the 2020 AAPS PharmSci 360 virtual show, October 26th – November 5th. We are excited to highlight our solutions for continuous manufacturing, wet granulation, capsule filling, tablet pressing, and more. Our experts will be available to discuss …more
The Supply Side West trade show may not be happening this year, but Syntegon is still here for you. We have multiple solid dosage stock machines available for quick delivery. Please see below for a current snapshot of what we can deliver from stock with quick turnaround. …more
In recent decades there has been a significant increase in the number of highly potent active pharmaceutical ingredients (HPAPIs) being developed, with some analysts predicting continued growth of this sector of 10% or more in the coming years. For Oral Solid Dosage (OSD) drug product manufacturers, handling of such potent drugs can present a number of challenges, including …more
COVID-19 has caused our fall trade show season to look a little different this year. Be sure to join Syntegon Pharma at these upcoming virtual trade shows. We look forward to “seeing” you there! …more
Syntegon’s goal is to make life easier for consumers, patients and customers. This is especially important in times of crisis like the current Corona pandemic. When travel restrictions reduce personal contact to a minimum, other means of communication are required to make sure that time-critical projects do not come to a standstill. Working from home and holding meetings online were obvious alternatives in many business contexts. But what about formats that should be taking place on site? …more
There is no doubt that the current and future outlook for nutraceutical companies manufacturing capsules and tablets will continue to flourish, so how can we present and offer solutions for this burgeoning market? The answer lies in understanding the challenges manufacturers face and the opportunities presented by wet granulation and how effectively this process can be implemented into manufacturing. Globally, …more
